Search results
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
Forbes· 3 days agoThe conference was a big one for Summit Therapeutics, which saw its stock price more than double...
Most CEOs are defeating attempts to vote down their pay. Can Tesla's Elon Musk do the same?
Yahoo Finance· 16 hours agoMost bosses are defeating shareholder attempts so far this year to tamp down their pay. The question...
Hedge Funds are Bullish on This Gene Therapy Stock
Insider Monkey via Yahoo Finance· 5 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss Gilead Sciences, Inc. (NASDAQ:GILD), which is...
Most CEOs are defeating attempts to vote down their pay. Can Tesla's Elon Musk do the same?
AOL· 16 hours agoThe question now is whether Tesla CEO Elon Musk can do the same. Just two companies out of 340 that held shareholder votes on CEO pay as of June 6 had their executive pay packages rejected, ...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks· 2 days agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective response rate of almost 52% in certain heavily pre-treated patients with ovarian cancer.
Cellectis gets EU orphan drug designation for UCART22 for ALL (NASDAQ:CLLS)
Seeking Alpha· 4 days agoCellectis (CLLS) has received orphan drug designation from EU regulators for its allogeneic CAR-T...
U.S. Stocks Close On Mixed Note
RTT News· 5 days agoAfter a positive start and a subsequent retreat that resulted in a fairly long spell in negative territory on Monday, U.S. stocks recovered in afternoon trades and ended the day's session on ...
Move over 'Magnificent 7,' the 'Fantastic 5' may offer higher earnings and return potential
CNBC· 3 days agoLooking for a less risky way to find growth stocks amid all the artificial intelligence hype?...
FTSE 100 Live 3 June: New York trading glitch sparks volatility, GSK shares tumble
Evening Standard via Yahoo Finance· 5 days agoGSK shares are today’s major focus after the drugs giant’s defence against Zantac claims suffered a...
Head-To-Head Survey: Ionis Pharmaceuticals (NASDAQ:IONS) versus Nurix Therapeutics (NASDAQ:NRIX)
ETF DAILY NEWS· 4 days agoNurix Therapeutics (NASDAQ:NRIX – Get Free Report) and Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) are both medical companies, but which is the better stock? We ...